HS
Harsimran Singh Kalra
About Harsimran Singh Kalra
Harsimran Singh Kalra has 7 years in corporate governance. Holds Additional Director and Director roles. Currently with 5 companies, including Systole Remedies Private Limited and Janus Biotech India Private Limited. Engaged in General Business, Technology and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Systole Remedies Private Limited
U24230DL2005PTC191854
|
Additional Director | 17 Jul 2021 | 2005 | Active |
Janus Biotech India Private Limited
U51909CH2019PTC042503
|
Director | 07 May 2019 | 2019 | Active |
Flanca Life Sciences Private Limited
U51909CH2022PTC044768
|
Director | 30 Dec 2022 | 2022 | Active |
Burgeon Health Series Private Limited
U51909CH2021PTC044123
|
Director | 31 Dec 2021 | 2021 | Active |
|
Nyx Pharmaceuticals Private Limited
U51909CH2019PTC042632
|
Director | 22 Jul 2019 | 2019 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harsimran Singh Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harsimran Singh Kalra
Harsimran Singh Kalra has 7 years in corporate governance. Holds Additional Director and Director roles. Currently with 5 companies, including Systole Remedies Private Limited and Janus Biotech India Private Limited. Engaged in General Business, Technology and more. Contributes to corporate operations.
Harsimran Singh Kalra is associated with 5 companies as Additional Director and Director.
Harsimran Singh Kalra has expertise in General Business, Technology and other sectors.
Harsimran Singh Kalra has 7 years in corporate governance.